Rationale for bipolar androgen therapy (BAT) for metastatic prostate cancer

John T. Isaacs, W. Nathaniel Brennen, Samuel R. Denmeade

Research output: Contribution to journal › Comment/debate › peer-review

3 Scopus citations

Fingerprint

Dive into the research topics of 'Rationale for bipolar androgen therapy (BAT) for metastatic prostate cancer'. Together they form a unique fingerprint.